Literature DB >> 7396431

Metrizamide encephalopathy.

F M Vincent, J E Zimmerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7396431     DOI： 10.1002/ana.410070522

Source DB:  PubMed          Journal:  Ann Neurol        ISSN： 0364-5134            Impact factor:   10.422


× No keyword cloud information.
  4 in total

1.  Influence of certain factors on the manifestations of the adverse effects of metrizamide myelography.

Authors:  Y L Yu; G H du Boulay; E Paul
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

2.  Triphasic EEG discharges in metrizamide encephalopathy.

Authors:  M E Drake; C W Erwin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-03       Impact factor: 10.154

3.  Is there an increased risk of early side effects of metrizamide in post-myelogram computed tomography?

Authors:  Y L Yu; G H du Boulay
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

4.  Non-ionic water soluble contrast medium 3-deoxy-3-iodo-D-glucose (DIG) for use in the CSF space. An experimental study with mongrel and beagle dogs.

Authors:  S Suzuki; K Ebina; T Sekiya; T Iwabuchi
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.